ASCO 2022 Biomarker Analysis of the NeoALTTO Trial Provides Oncofertility Insight for Younger Breast Cancer Pts | VuMedi

ecancer

ASCO 2022 Biomarker Analysis of the NeoALTTO Trial Provides Oncofertility Insight for Younger Breast Cancer Pts

By ecancer FEATURING Matteo Lambertini

By ecancer FEATURING Matteo Lambertini

2 views

June 17, 2022

0 Comments

Login to view comments. Click here to Login